LIM-domain-only proteins: Multifunctional nuclear transcription coregulators that interacts with diverse proteins

Molecular Biology Reports

Volumn 41, Issue 2, 2014, Pages 1067-1073

  Sang, Meixiang ^a,b   Ma, Li ^a   Sang, Meijie ^a,b   Zhou, Xinliang ^a   Gao, Wei ^a   Geng, Cuizhi ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Gene transcription; LDB1; LIM domain; LMO; Protein protein interaction

Indexed keywords

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; HUMANS; LIM DOMAIN PROTEINS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84899438812     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2952-1     Document Type: Review

References (86)

1. Sanchez-Garcia I, Rabbitts TH (1994) The LIM domain: a new structural motif found in zinc-finger-like proteins. Trend Genet 10:315-320 (Pubitemid 24277664)
2. Dawid IB, Toyama R, Taira M (1995) LIM domain proteins. C R Acad Sci III 318:295-306
3. Bach I (2000) The LIM domain: regulation by association. Mech Dev 91:5-17
4. Jurata LW, Gill GN (1998) Structure and function of LIM domains. Curr Top Microbiol Immunol 228:75-113 (Pubitemid 27504958)
5. Dawid IB, Breen JJ, Tayama R (1998) LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet 14:156-162 (Pubitemid 28206396)
6. Deane JE, Ryan DP, Sunde M, Maher MJ, Guss JM, Visvader JE, Matthews JM (2004) Tandem LIM domains provide synergistic binding in the LMO4: ldb1 complex. EMBO J 23:3589-3598 (Pubitemid 39336281)
7. Matthews JB, Johnson DR, Lazari O, Craig R, Matthews KR (2008) Identification of a LIM domain-containing gene in the Cyathostominae. Vet Parasitol 154:82-93
8. Heberlein U, Tsai LT, Kapfhamer D, Lasek AW (2009) Drosophila, a genetic model system to study cocaine-related behaviors: a review with focus on LIM-only proteins. Neuropharmacology 56:97-106
9. Patterson LJ, Gering M, Eckfeldt CE, Green AR, Verfaillie CM, Ekker SC, Patient R (2007) The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish. Blood 109:2389-2398 (Pubitemid 46425879)
10. McCollum CW, Amin SR, Pauerstein P, Lane ME (2007) A zebrafish LMO4 ortholog limits the size of the forebrain and eyes through negative regulation of six3b and rx3. Dev Biol 309:373-385 (Pubitemid 47361108)
11. Rétaux S, Bachy I (2002) A short history of LIM domains (1993-2002): from protein interaction to degradation. Mol Neurobiol 26:269-281 (Pubitemid 35239804)
12. Boehm T, Baer R, Lavenir I, Forster A, Waters JJ, Nacheva E, Rabbitts TH (1998) The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J 7:385-394
13. Boehm T, Foroni L, Kennedy M, Rabbitts TH (1990) The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. Oncogene 5:1103-1105
14. McGuire EA, Hockett RD, Pollock KM, Bartholdi MF, O'Brien SJ, Korsmeyer SJ (1989) The t(11;14) (p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol 9:2124-2132 (Pubitemid 19117813)
15. Boehm T, Foroni L, Kaneko Y, Perutz MF, Rabbitts TH (1991) The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci USA 88:4367-4371 (Pubitemid 21914541)
16. Foroni L, Boehm T, White L et al (1992) The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development. J Mol Biol 226:747-761
17. Royer-Pokora B, Loos U, Ludwig WD (1991) TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14) (p13;q11). Oncogene 6:1887-1893 (Pubitemid 21924023)
18. Grutz G, Forster A, Rabbitts TH (1998) Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T-cell acute leukaemia. Oncogene 7:2799-2803 (Pubitemid 28554239)
19. Kenny DA, Jurata LW, Saga Y, Gill GN (1998) Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis. Proc Natl Acad USA 95:11257-11262 (Pubitemid 28450115)
20. Sugihara TM, Bach I, Kioussi C, Rosenfeld MG, Andersen B (1998) Mouse deformed epidermal autoregulatory factor 1 recruits a LIM domain factor, LMO-4, and CLIM coregulators. Proc Natl Acad Sci USA 95:15418-15423 (Pubitemid 29018713)
21. Racevskis J, Dill A, Sparano JA, Ruan H (1999) Molecular cloning of LMO41, a new human LIM domain gene. Biochim Biophys Acta 1445:148-153 (Pubitemid 29193216)
22. Tse E, Smith AJ, Hunt S et al (2004) Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice. Mol Cell Biol 24:2063-2073 (Pubitemid 38248945)
23. Hahm K, Sum EY, Fujiwara Y, Lindeman GJ, Visvader JE, Orkin SH (2004) Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1. Mol Cell Biol 24:2074-2082 (Pubitemid 38248946)
24. Valge-Archer V, Forster A, Rabbitts TH (1998) The LMO1 and LDB1 proteins interact in human T-cell acute leukaemia with the chromosomal translocation t(11;14) (p15;q11). Oncogen 17:3199-3202 (Pubitemid 29020815)
25. Larson RC, Fisch P, Larson TA, Lavenir I, Langford T, King G, Rabbitts TH (1994) T-cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene 9:3675-3681 (Pubitemid 24359406)
26. Larson RC, Lavenir I, Larson TA, Baer R, Warren AJ, Wadman I, Nottage K, Rabbitts TH (1996) Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T-cell tumorigenesis in transgenic mice. EMBO J 15:1021-1027 (Pubitemid 26077830)
27. Tremblay M, Tremblay CS, Herblot S, Aplan PD, Hebert J, Perreault C, Hoang T (2010) Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev 24:1093-1105
28. Wang K, Diskin SJ, Zhang H et al (2011) Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 469:216-220
29. Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH (1994) The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78:45-57 (Pubitemid 24228299)
30. Yamada Y, Warren AJ, Dobson C, Forster A, Pannell R, Rabbitts TH (1998) The T-cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci USA 95:3890-3895 (Pubitemid 28173224)
31. Rabbitts TH (1998) LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev 12:2651-2657
32. Yamada Y, Pannell R, Rabbits TH (2000) The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis. Proc Natl Acad Sci USA 97:320-324 (Pubitemid 30055829)
33. Look AT (1997) Oncogenic transcription factors in the human acute leukemias. Science 278:1059-1064
34. Hwang LY, Baer RJ (1995) The role of chromosome translocations in T-cell acute leukemia. Curr Opin Immunol 7:659-664
35. Hammond SM, Crable SC, Anderson KP (2005) Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. Leuk Res 19:89-97
36. Dik WA, Nadel B, Przybylski GK et al (2007) Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL. Blood 110:388-392 (Pubitemid 47026860)
37. Hacein-Bey-Abina S, Von Kalle C et al (2003) LMO2-associated clonal T-cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419 (Pubitemid 37296260)
38. Van Vlierberghe P, van Grotel M, Beverloo HB et al (2006) The cryptic chromosomal deletion del(11) (p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 108:3520-3529
39. Appert A, Nam CH, Lobato N et al (2009) Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia. Cancer Res 69:4784-4790
40. Alizadeh AA, Eisen MB, Davis RE et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511 (Pubitemid 30082188)
41. Natkunam Y, Farinha P, his ED et al (2008) LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. J Clin Oncol 26:447-454 (Pubitemid 351171698)
42. Natkunam Y, Zhao S, Mason DY et al (2007) The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 109:1636-1642 (Pubitemid 46239598)
43. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, Levy R (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350:1828-1837 (Pubitemid 38917249)
44. Ma S, Guan XY, Bech PS, Wong KY, Chan YP, Yuen HF, Vielkind J, Chan KW (2007) The significance of LMO2 expression in the progression of prostate cancer. J Pathol 211:278-285 (Pubitemid 46172703)
45. Nakata K, Ohuchida K, Nagai E et al (2009) LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer. Neoplasia 11:712-719
46. Wadman I, Li J, Bash RO, Forster A, Osada H, Rabbitts TH, Baer R (1994) Specific in vivo association between the bHLH and LIM proteins implicated in human T-cell leukemia. EMBO J 13:4831-4839 (Pubitemid 24319365)
47. Valge-Archer VE, Osada H, Warren AJ, Forster A, Li J, Baer R, Rabbitts TH (1994) The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci USA 91:8617-8621
48. Wadman IA, Osada H, Grütz GG, Agulnick AD, Westphal H, Forster A, Rabbitts TH (1997) The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J 16:3145-3157 (Pubitemid 27234954)
49. Grütz GG, Bucher K, Lavenir I, Larson T, Larson R, Rabbitts TH (1998) The oncogenic T-cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T-cells. EMBO J 17:4594-4605 (Pubitemid 28377160)
50. Han C, Liu H, Liu J et al (2005) Human Bex2 interacts with LMO2 and regulates the transcriptional activity of a novel DNA-binding complex. Nucleic Acids Res 33:6555-6565 (Pubitemid 41806420)
51. Hink GL, Shah B, French SJ, Campos LS, Staley K, Hughes J, Sofroniew MV (1997) Expression of LIM protein genes Lmo1, Lmo2, and Lmo3 in adult mouse hippocampus and other forebrain regions: differential regulation by seizure activity. J Neurosci 17:5549-5559
52. Shi J, Cai W, Chen X, Ying K, Zhang K, Xie Y (2001) Identification of dopamine responsive mRNAs in glial cells by suppression subtractive hybridization. Brain Res 910:29-37 (Pubitemid 32727325)
53. Bao J, Talmage DA, Role LW, Gautier J (2000) Regulation of neurogenesis by interactions between HEN1 and neuronal LMO proteins. Development 127:425-435 (Pubitemid 30087977)
54. Aoyama M, Ozaki T, Inuzuka H, Tomotsune D, Hirato J, Okamoto Y, Tokita H, Ohira M, Nakagawara A (2005) LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma. Cancer Res 65:4587-4597 (Pubitemid 40740794)
55. Isogai E, Ohira M, Ozaki T, Oba S, Nakamura Y, Nakagawara A (2010) Oncogenic LMO3 collaborates with HEN2 to enhance neuroblastoma cell growth through transactivation of Mash1. PLoS One 6:e19297
56. Hui L, Ji C, Hui B, Lv T, Ha X, Yang J, Cai W (2009) The oncoprotein LMO3 interacts with calcium- and integrin-binding protein CIB. Brain Res 1265:24-29
57. Larsen S, Yokochi T, Isogai E, Nakamura Y, Ozaki T, Nakagawara A (2010) LMO3 interacts with p53 and inhibits its transcriptional activity. Biochem Biophys Res Commun 392:252-257
58. Watanabe H, Francis JM, Woo MS et al (2013) Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target. Genes Dev 27:197-210
59. Visvader JE, Venter D, Hahm K et al (2001) The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer. Proc Natl Acad USA 98:14452-14457 (Pubitemid 33121412)
60. Wang N, Kudryavtseva E, Chen IL, McCormick J, Sugihara TM, Ruiz R, Andersen E (2004) Expression of an engrailed-LMO4 fusion protein in mammary epithelial cells inhibits mammary gland development in mice. Oncogene 23:1507-1513 (Pubitemid 38406512)
61. Sum EY, Segara D, Duscio B, Bath ML, Field AS, Sutherland RL, Lindeman GJ, Visvader JE (2005) Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer. Proc Natl Acad USA 102:7659-7664 (Pubitemid 40741027)
62. Wang N, Lin KK, Lu Z, Lam KS, Newton R, Xu X, Yu Z, Gill GN, Andersen B (2007) The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene 26:6431-6441 (Pubitemid 47494218)
63. Montañez-Wiscovich ME, Seachrist DD, Landis MD, Visvader J, Andersen B, Keri RA (2009) LMO4 is an essential mediator of ErbB2/HER2/Neu- induced breast cancer cell cycle progression. Oncogene 28:3608-3618
64. Montañez-Wiscovich ME, Shelton MD, Seachrist DD, Lozada KL, Johnson E, Miedler JD, Abdul-Karim FW, Visvader JE, Keri RA (2010) Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells. J Pathol 222:271-281
65. Zhou X, Sang M, Liu W et al (2012) LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53. Life Sci 91:358-363
66. Tian Y, Wang N, Lu Z (2010) Repression of Lim only protein 4-activated transcription inhibits proliferation and induces apoptosis of normal mammary epithelial cells and breast cancer cells. Clin Exp Metastasis 27:455-463
67. Sum EY, Peng B, Yu X, Chen J, Byrne J, Lindeman GJ, Visvader JE (2002) The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity. J Biol Chem 27:7849-7856 (Pubitemid 34968233)
68. Singh RR, Barnes CJ, Talukder AH, Fuqua SA, Kumar R (2005) Negative regulation of estrogen receptor a transactivation function by LIM domain only 4 protein. Cancer Res 65:10594-10601 (Pubitemid 41743755)
69. Begley CG, Lipkowitz S, Göbel V, Mahon KA, Bertness V, Green AR, Gough NM, Kirsch IR (1992) Molecular characterization of NSCL, a gene encoding a helix-loop-helix protein expressed in the developing nervous system. Proc Natl Acad USA 89:38-42
70. Manetopoulos C, Hansson A, Karlsson J, Jönsson JI, Axelson H (2003) The LIM-only protein LMO4 modulates the transcriptional activity of HEN1. Biochem Biophys Res Commun 307:891-899 (Pubitemid 36871657)
71. Lu Z, Lam KS, Wang N, Xu X, Cortes M, Andersen B (2006) LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelia cells. Oncogene 25:2920-2930 (Pubitemid 43739242)
72. Schock SC, Xu J, Duquette PM et al (2008) Rescue of neurons from ischemic injury by peroxisome proliferation-activated receptor-γ requires a novel essential cofactor LMO4. J Neurosci 28:12433-12444
73. Schaffar G, Taniguchi J, Brodbeck T, Meyer AH, Schmidt M, Yamashita T, Mueller BK (2008) LIM-only protein 4 interacts directly with the repulsive guidance molecule A receptor Neogenin. J Neurochem 107:418-431
74. Kashani AH, Qiu Z, Jurata L, Lee SK, Pfaff S, Goebbels S, Nave KA, Ghosh A (2006) Calcium activation of the LMO4 transcription complex and its role in the patterning of thalamocortical connections. J Neurosci 26:8398-8408 (Pubitemid 44309854)
75. Novotny-Diermayr V, Lin B, Gu L, Cao X (2005) Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction. J Biol Chem 280:12747-12757
76. Michell AC, Bragança J, Broadbent C, Joyce B, Franklyn A, Schneider JE, Bhattacharya S, Bamforth SD (2010) A novel role for transcription factor Lmo4 in thymus development through genetic interaction with Cited2. Dev Dyn 239:1988-1994
77. Chen HH, Schock SC, Xu J, Safarpour F, Thompson CS, Stewart AF (2007) Extracellular ATP-dependent upregulation of the transcription cofactor LMO4 promotes neuron survival from hypoxia. Exp Cell Res 313:3106-3116 (Pubitemid 47125879)
78. Chen HH, Xu J, Safarpour F, Stewart AF (2007) LMO4 mRNA stability is regulated by extracellular ATP in F11 cells. Biochem Biophys Res Commun 357:56-61 (Pubitemid 46574499)
79. Lee SK, Jurata LW, Nowak R, Lettieri K, Kenny DA, Pfaff SL, Gill GN (2005) The LIM domain-only protein LMO4 is required for neural tube closure. Mol Cell Neurosci 28:205-214 (Pubitemid 40202583)
80. Murphy NC, Scarlett CJ, Kench JG et al (2008) Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma. Br J Cancer 98:537-541 (Pubitemid 351214516)
81. Yu J, Ohuchida K, Nakata K et al (2008) LIM only 4 is overexpressed in late stage pancreas cancer. Mol Cancer 7:93
82. Agulnick D, Taira M, Breen JJ, Tanaka T, Dawid IB, Westphal H (1996) Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature 384:270-272 (Pubitemid 26396977)
83. Jurata LW, Gill GN (1997) Functional analysis of the nuclear LIM domain interactor NLI. Mol Cell Biol 17:5688-5698 (Pubitemid 27411076)
84. Mulkhopadhyay M, Teufel A, Yamashita T et al (2003) Functional ablation of the mouse Ldb1 gene results in severe patterning defects during gastrulation. Development 130:495-505 (Pubitemid 36231269)
85. Matthews JM, Visvader JE (2003) LIM-domain-binding protein 1: a multifunctional cofactor that interacts with diverse proteins. EMBO Rep 4:1127-1132
86. Nam CH, Lobato MN, Appert A, Drynan LF, Tanaka T, Rabbitts TH (2008) An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions. Oncogene 27:4962-4968